Expression of c-MET in Estrogen Receptor Positive and HER2 Negative Resected Breast Cancer Correlated with a Poor Prognosis

Introduction: The mesenchymal-epithelial transition factor (c-MET) receptor is overexpressed in about 14–54% of invasive breast cancers, but its prognostic value in clinical practice is still unclear. Methods: In order to investigate the relationship between c-MET expression levels and prognosis, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Iovino, Francesco, Diana, Anna, Carlino, Francesca, Ferraraccio, Franca, Antoniol, Giuliano, Fisone, Francesca, Perrone, Alessandra, Zito Marino, Federica, Panarese, Iacopo, Tathode, Madhura S., Caraglia, Michele, Gatta, Gianluca, Ruggiero, Roberto, Parisi, Simona, De Vita, Ferdinando, Ciardiello, Fortunato, Docimo, Ludovico, Orditura, Michele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738605/
https://www.ncbi.nlm.nih.gov/pubmed/36498560
http://dx.doi.org/10.3390/jcm11236987

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738605/
https://www.ncbi.nlm.nih.gov/pubmed/36498560
http://dx.doi.org/10.3390/jcm11236987

Ejemplares similares